Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.83), $0.51 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $5.74 million versus the consensus estimate of $9.72 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Alzamend Neuro lithium trial data accepted for Barcelona MRI workshop
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
